Experimental Treatment of Ebola Virus Disease with TKM-130803: A Single-Arm Phase 2 Clinical Trial IDDO_EORKWS

Domaine:

healthcare

Type de record:

dataset

Créateur:

Uni

Éditeur:

Inf

Hôte:

Patient records from open-label, single arm trial to investigate the efficacy of TKM-130803 collected by Oxford University during the 2013-2016 West African Ebola outbreak. It has been curated to the CDISC SDTM data standard at the individual participant-level for 17 participants. Further information about the data available in this dataset can be found on the IDDO website.

Experimental treatment of Ebola virus disease with brincidofovir

The nucleotide analogue brincidofovir was developed to prevent and treat infections caused by double

Experimental Treatment of Ebola Virus Disease with Brincidofovir IDDO_EBPOHA

Patient records from the clinical trial titled Experimental Treatment of EVD with Brincidofovir, col

Pharmacokinetics of TKM-130803 in Sierra Leonean patients with Ebola virus disease: plasma concentrations exceed target levels, with drug accumulation in the most severe patients.

BACKGROUND: TKM-130803 is a specific anti-EBOV therapeutic comprised of two small interfering RNAs (

Treatment of chronic hepatitis C virus infection in Rwanda with ledipasvir-sofosbuvir (SHARED): a single-arm trial.

BACKGROUND: Limited treatment data are available for hepatitis C virus (HCV) in

Regulatory and operational complexities of conducting a clinical treatment trial during an Ebola Virus Disease epidemic

The first Phase II and III clinical trials for treatments for Ebola Virus Disease were conducted dur

PREVAIL IV: A Randomized, Double-Blind, 2-Phase, Phase 2 Trial of Remdesivir vs Placebo for Reduction of Ebola Virus RNA in the Semen of Male Survivors

Abstract Background Ebola virus RNA persist

Experimental Treatment of Ebola Virus Disease with TKM-130803: A Single-Arm Phase 2 Clinical Trial IDDO_EORKWS

Domaine:

Type de record:

Visit

Tags